Ivan Kairatov stands at the forefront of biopharmaceutical innovation, bringing years of dedicated research in oncology to the challenge of treating refractory cancers. His recent collaborative work with international teams from the Netherlands, Italy, and Slovakia has shed new light on germ cell
We are joined today by Ivan Kairatov, a biopharma expert whose groundbreaking research is rewriting our fundamental understanding of how we learn. For over a century, we've believed that repetition is the key to learning, but his work reveals that timing is the far more critical ingredient. Our
A groundbreaking study has fundamentally altered the scientific understanding of prenatal exposure to per- and polyfluoroalkyl substances (PFAS), revealing that the chemical burden on newborns is substantially more widespread and complex than previously documented. By employing a novel,
A transformative artificial intelligence tool promises to redefine cardiac care by enabling a standard imaging technique to see what was previously invisible: the specific arterial plaques most likely to cause a catastrophic heart attack. Researchers at the Korea Advanced Institute of Science and
A groundbreaking artificial intelligence method offers a profound new capability in cardiovascular diagnostics, enabling clinicians to identify high-risk fatty deposits within coronary arteries with unprecedented accuracy. This innovative system, developed by a dedicated research team from the
When was the last time you comparison-shopped for an MRI? The federal government wagered that turning healthcare into a retail experience would save us all money. Here’s why that bet hasn't paid off A federal initiative promising to pull back the curtain on healthcare pricing has instead armed
